Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bertrand

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Expert Opinion on Therapeutic Targets|December 13, 2012
Alpha7 neuronal nicotinic receptors as a drug target in schizophreniaTanya L Wallace, Daniel Bertrand
Biochemical Pharmacology|September 19, 2006
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptorsRon C Hogg, Daniel Bertrand
Annual Review of Pharmacology and Toxicology|October 3, 2006
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous systemJohn A Dani, Daniel Bertrand
Current Topics in Behavioral Neurosciences|May 27, 2020
A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain DisordersDaniel Bertrand, Tanya L Wallace
Pflugers Archiv : European Journal of Physiology|December 18, 2009
Nicotinic receptor channelopathies and epilepsyOrtrud K Steinlein, Daniel Bertrand
International Review of Neurobiology|October 17, 2015
Neuronal α7 Nicotinic Receptors as a Target for the Treatment of SchizophreniaTanya L Wallace, Daniel Bertrand
Biochemical Pharmacology|December 18, 2017
The wonderland of neuronal nicotinic acetylcholine receptorsDaniel Bertrand, A V Terry
Biochemical Pharmacology|March 30, 2010
Associated proteins: The universal toolbox controlling ligand gated ion channel functionTanguy Araud, Susan Wonnacott, Daniel Bertrand
Pharmacology & Therapeutics|August 29, 2012
Nicotinic acetylcholine receptors: from basic science to therapeuticsRaymond Hurst, Hans Rollema, Daniel Bertrand
Journal of Visualized Experiments : Jove|September 4, 2018
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A NeurotransmissionFrédéric Knoflach, Maria-Clemencia Hernandez, Daniel Bertrand
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Expert Opinion on Therapeutic Targets|December 13, 2012
Alpha7 neuronal nicotinic receptors as a drug target in schizophreniaTanya L Wallace, Daniel Bertrand
Biochemical Pharmacology|September 19, 2006
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptorsRon C Hogg, Daniel Bertrand
Annual Review of Pharmacology and Toxicology|October 3, 2006
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous systemJohn A Dani, Daniel Bertrand
Current Topics in Behavioral Neurosciences|May 27, 2020
A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain DisordersDaniel Bertrand, Tanya L Wallace
Pflugers Archiv : European Journal of Physiology|December 18, 2009
Nicotinic receptor channelopathies and epilepsyOrtrud K Steinlein, Daniel Bertrand
International Review of Neurobiology|October 17, 2015
Neuronal α7 Nicotinic Receptors as a Target for the Treatment of SchizophreniaTanya L Wallace, Daniel Bertrand
Biochemical Pharmacology|December 18, 2017
The wonderland of neuronal nicotinic acetylcholine receptorsDaniel Bertrand, A V Terry
Biochemical Pharmacology|March 30, 2010
Associated proteins: The universal toolbox controlling ligand gated ion channel functionTanguy Araud, Susan Wonnacott, Daniel Bertrand
Pharmacology & Therapeutics|August 29, 2012
Nicotinic acetylcholine receptors: from basic science to therapeuticsRaymond Hurst, Hans Rollema, Daniel Bertrand
Journal of Visualized Experiments : Jove|September 4, 2018
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A NeurotransmissionFrédéric Knoflach, Maria-Clemencia Hernandez, Daniel Bertrand
Pageof 13